Interferon-γ release assays versus tuberculin skin test for targeting people for tuberculosis preventive treatment: An evidence-based review

Journal of Infection

Volumn 66, Issue 4, 2013, Pages 381-387

  Muñoz, Laura ^a   Santin, Miguel ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Interferon gamma release assays; Latent tuberculosis infection; QuantiFERON TB Gold in tube; Systematic review; T SPOT.TB; Tuberculin skin test; Tuberculosis

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; HIGH INCOME GROUP; HUMAN; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; LOWEST INCOME GROUP; MIDDLE INCOME GROUP; PREVALENCE; SCREENING TEST; SOCIAL STATUS; SYSTEMATIC REVIEW; TUBERCULIN TEST; TUBERCULOSIS;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84875506757     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.12.005     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention Essential components of a tuberculosis prevention and control program: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1995, 44(RR-11):1-16.
2. Chan-Yeung M., Tam C.M., Wong H., Leung C.C., Wang J., Yew W.W., et al. Molecular and conventional epidemiology of tuberculosis in Hong Kong: a population-based prospective study. J Clin Microbiol 2003, 41:2706-2708.
3. Smieja M., Marchetti C., Cook D., Smaill F.M. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000, 2:CD001363.
4. Akolo C., Adetifa I., Shepperd S., Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev 2010, 1:CD000171.
5. Horsbourgh C.R. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004, 350:2060-2067.
6. Rangaka M.X., Wilkinson K.A., Glynn J.R., Ling D., Menzies D., Mwansa-Kambafwile J., et al. Predictive value of interferon-γ assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:44-55.
7. Diel R., Loddenkemper R., Nienhaus A. Predictive value of interferon-gamma release assays and tuberculin skin testing for predicting progression from latent TB infection to disease state: a meta-analysis. Chest 2012, 142:63-75.
8. Hirsch-Moverman Y., Daftary A., Franks J., Colson P.W. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis 2008, 12:1235-1254.
9. Pai M., Zwerling A., Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149:177-184.
10. Matulis G., Jüni P., Villiger P.M., Gadola S.D. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis 2008, 67:84-90.
11. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e000097. The PRISMA Group.
12. Whiting P.F., Weswood M.E., Rutjes A.W.S., Reitsma J.B., Bossuyt P.N., Kleijnen J., et al. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 2006, 6:9.
13. Wells GA, Shea B, O'Connell D, Peterson J, Weich V. The Newcasttle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at:. [accessed 16.08.11]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
14. World Bank Group. Available at:. [accessed 01.12.12]. http://www.worldbank.org.
15. Wallace B.C., Schmid C.H., Lau J., Trikalinos T.A. Meta-analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol 2009, 9:80.
16. Song S., Jeon D., Kim J.W., Kim Y.D., KIM S.P., Cho J.S., et al. Performance of confirmatory interferon-gamma release assays in school TB outbreaks. Chest 2012, 141:983-988.
17. Kik S.V., Franken W.P.J., Mensen M., Cobelens F.G., Kamphorst M., Arend S.M., et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 2010, 35:1346-1353.
18. Diel R., Loddenkemper R., Niemann S., Meywald-Walter K., Nienhaus A. Negative and positive predictive value of a whole-blood interferon-gamma release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med 2011, 183:88-95.
19. Laffite E., Janssens J.P., Roux-Lombard P., Thielen A.M., Barde C., Marazza G., et al. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-γ release assay vs. tuberculin skin test. Br J Dermatol 2009, 161:797-800.
20. Garcovich S., Ruggeri A., D'Agostino M., Ardito F., De Simone C., Delogu G., et al. Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study. J Eur Acad Dermatol Venereol 2012, 26:1572-1576.
21. ®-TB Gold testing in screening for tuberculosis disease in asylum seekers. Int J Tuberc Lung Dis 2010, 14:1209-1211.
22. Bakir M., Millington K.A., Soysal A., Deeks J.J., Efee S., Aslan Y., et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med 2008, 149:777-786.
23. Chang B., Park H.Y., Jeon K., Ahn J.K., Cha H.S., Koh E.M., et al. Interferon-gamma release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. Clin Rheumatol 2011, 30:1535-1541.
24. Hill P.C., Jackson-Sillah D.J., Fox A., Brookes R.H., de Jong B.C., Lugos M.D., et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux test in Gambian case contacts. PLoS One 2008, 3:e1379.
25. Leung C.C., Yam W.C., Yew W.W., Ho P.L., Tam C.M., Law W.S., et al. T-Spot.TB outperforms tuberculin skin test in predicting tuberculosis disease. Am J Respir Crit Care Med 2010, 182:834-840.
26. Mahomed H., Hawkridge T., Verver S., Geiter L., Hatherill M., Abrahams D.A., et al. The tuberculin skin test versus QuantiFERON-TB Gold in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One 2011, 6:e17984.
27. Anibarro L., Trigo M., Villaverde C., Pena A., Cortizo S., Sande D., et al. Interferon-gamma release assays in tuberculosis contacts: is there a window period?. Eur Respir J 2011, 37:215-217.
28. Aichelburg M.C., Rieger A., Breitenecker F., Pfistershammer K., Tittes J., Eltz S., et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis 2009, 48:954-962.
29. World Health Organization (WHO). Available at:. [accessed 01.09.11]. http://whqlibdoc.who.int/hq/2011/WHO_HTM_TB_2011.17_eng.pdf.